These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Paraganglioma behaving like a pheochromocytoma. Sundaram M N Engl J Med; 1977 Aug; 297(7):401. PubMed ID: 876341 [No Abstract] [Full Text] [Related]
5. The association of neurofibromatosis, pheochromocytoma, and somatostatin-rich duodenal carcinoid tumor. Wheeler MH; Curley IR; Williams ED Surgery; 1986 Dec; 100(6):1163-9. PubMed ID: 2878497 [TBL] [Abstract][Full Text] [Related]
6. Current status of catecholamines and their implication in various diseases. Uddin M; Green P Manit Med Rev; 1967 Dec; 47(10):561-6. PubMed ID: 4867045 [No Abstract] [Full Text] [Related]
7. Chemistry and pharmacology of catecholamine-secreting tumors. von Studnitz W Pharmacol Rev; 1966 Mar; 18(1):645-50. PubMed ID: 5904176 [No Abstract] [Full Text] [Related]
8. Catecholamine-producing neural tumors other than pheochromocytoma. Käser H Pharmacol Rev; 1966 Mar; 18(1):659-65. PubMed ID: 5904178 [No Abstract] [Full Text] [Related]
9. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites? Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206 [TBL] [Abstract][Full Text] [Related]
10. Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells. Bayer M; Kuçi Z; Schömig E; Gründemann D; Dittmann H; Handgretinger R; Bruchelt G Nucl Med Biol; 2009 Apr; 36(3):287-94. PubMed ID: 19324274 [TBL] [Abstract][Full Text] [Related]
11. [Regulatory processes of intra and extracerebral circulation in halothane induced blood pressure lowering]. Felix R; Thurn P; Havers L; Betz H Radiologe; 1969 Jan; 9(1):1-3. PubMed ID: 4909396 [No Abstract] [Full Text] [Related]
15. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors. Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172 [TBL] [Abstract][Full Text] [Related]
16. Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function. Rapizzi E; Fucci R; Giannoni E; Canu L; Richter S; Cirri P; Mannelli M Endocr Relat Cancer; 2015 Jun; 22(3):409-17. PubMed ID: 25808177 [TBL] [Abstract][Full Text] [Related]
17. [Biological diagnosis of pheochromocytomas and paragangliomas]. d'Herbomez M; Rouaix N; Bauters C; Wémeau JL Presse Med; 2009 Jun; 38(6):927-34. PubMed ID: 19135846 [TBL] [Abstract][Full Text] [Related]
18. [Characteristics of spectrum of pharmacological activity of hyndarine (1-tetrahydropalmatine) and its effect on the metaboli of catecholamines]. Berezhinskaia VV; Trutneva EA Farmakol Toksikol; 1966; 29(6):731-4. PubMed ID: 6000372 [No Abstract] [Full Text] [Related]
19. Catecholamine-secreting tumours and their clinical chemistry. Sandler M Ann Clin Biochem; 1976 Sep; 13(5):507-8. PubMed ID: 187108 [No Abstract] [Full Text] [Related]
20. Secretory characteristics of phaeochromocytoma and related tumours. Their diagnostic and clinical significance. Walters G Ann R Coll Surg Engl; 1969 Sep; 45(3):150-61. PubMed ID: 4310435 [No Abstract] [Full Text] [Related] [Next] [New Search]